PW Medtech GroupFRA:PWE 82 OCF Margin % is 33.39% as of Dec. 2025, which is 6% above its 10-year median of 31.53. GuruFocus rates FRA:PWE with a GF Score™ of 82/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, PW Medtech Group ranks better than 91.41% on this metric.
The historical rank and industry rank for PW Medtech Group's OCF Margin % or its related term are showing as below:
FRA:PWE'
s OCF Margin % Range Over the Past 10 Years
Min: 13.72 Med: 31.53 Max: 83.47
Current: 29.24
During the past 13 years, the highest OCF Margin % of PW Medtech Group was 83.47%. The lowest was 13.72%. And the median was 31.53%.
FRA:PWE's OCF Margin % is ranked better than 91.41% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs FRA:PWE: 29.24
PW Medtech Group OCF Margin % Related Terms
PW Medtech Group OCF Margin % Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PWE vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's OCF Margin % distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (FRA:PWE) has a OCF Margin % of 33.39% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PW Medtech Group and its competitors. This is near median its historical median of 31.53. Over the past decade, PW Medtech Group's OCF Margin % has ranged from 13.72 to 83.47. According to the industry distribution chart, PW Medtech Group ranks #70 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 8.6%.
Is PW Medtech Group's OCF Margin % too high?
PW Medtech Group's current OCF Margin % of 33.39% is near median its 10-year median of 31.53. Over the past 10 years, this metric has ranged from a low of 13.72 to a high of 83.47. The Medical Devices & Instruments industry median OCF Margin % is 5.86. PW Medtech Group's value of 33.39% is 469.8% above this industry median. Based on the distribution chart, PW Medtech Group ranks #70 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #70 out of 815 companies for OCF Margin %. This places PW Medtech Group in the top 9% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. PW Medtech Group's value of 33.39% is 469.8% above this benchmark. Historically, PW Medtech Group's own OCF Margin % has ranged from 13.72 to 83.47 over the past decade. While the company's 10-year median is 31.53 vs. the industry median of 5.86, PW Medtech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PW Medtech Group's current OCF Margin % of 33.39% is 469.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PW Medtech Group and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PW Medtech Group's current OCF Margin % is 33.39%, which is near median its own 10-year median of 31.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current OCF Margin % of 33.39%. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 15.4% below its estimated fair value. The current OCF Margin % is 33.39%, which is near median its 10-year median of 31.53 and 469.8% above the Medical Devices & Instruments industry median of 5.86. PW Medtech Group's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current OCF Margin % is 33.39% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.11 is trading 15.4% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:PWE:
OCF Margin %: 33.39% (near median its 10-year median of 31.53)
GF Value™: €0.13 vs. price of €0.11 (15.4% below fair value)
Industry Position: 469.8% above the Medical Devices & Instruments median (#70 of 815)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
82GF Score
Get the complete analysis for FRA:PWE
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
